Jauregi Zinkunegi, A, Gleason, CE, Bendlin, B, Okonkwo, O, Hermann, BP, Blennow, K, Zetterberg, H, Hogervorst, E, Johnson, SC, Langhough, R, Mueller, KD and Bruno, D Menopausal hormone therapy is ...

Obesity and cardiovascular risk factors accelerate brain volume loss, with males experiencing earlier and more significant ...

As with other disease states, biomarkers that can provide value across diagnosis, prognosis, and treatment response, have ...

Q: I keep reading about how important it is for your body to clear out damaged and dead cells, otherwise your risk for cancer ...

Muvalaplin reduces lipoprotein(a) levels, according to a study published online Nov. 20 in the Journal of the American ...

Hypertension, atrial fibrillation, and smoking were all strongly linked to a higher risk for severe stroke than non-severe ...

Okanagan Clinical Trials is pleased to announce the availability of new opportunities to participate in important clinical research studies testing key biomarkers for Alzheimer’s disease.

This week Novartis NVS upgraded its mid-term sales growth guidance. The European Commission approved Pfizer’s PFE hemophilia ...

I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial,” published in ...

In addition, reductions in triglycerides and atherogenic proteins such as apolipoprotein B (ApoB), lipoprotein (a) [Lp(a)], ...

Researchers have used machine learning and supercomputer simulations to investigate how tiny gold nanoparticles bind to blood proteins. The studies discovered that favorable nanoparticle-protein ...